- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00971386
Short Term Hemodynamic Effects of Controlled Slow Breathing With Biofeedback in Patients With Heart Failure
Short Term Hemodynamic Effects of Controlled Slow Breathing With Biofeedback in Patients With Heart Failure: Normal Healthy Subjects vs. Chronic Ambulatory Heart Failure Patients vs Acute Heart Failure
Heart failure is associated with faster breathing, which has a negative impact on the functioning of the heart. This leads to fatigue, shortness of breath, and exercise intolerance. It has been shown that when slow breathing technique was taught to patients with heart failure, they had a reduction in their sensation of shortness of breath and an improvement in their exercise performance.
The study will compare the short-term effects of controlled slow breathing with biofeedback in normal healthy subjects, acute heart failure, and chronic stable heart failure. The purpose is to see if there is any change in the objective measurements of heart function while breathing at normal rates compared to a controlled slower rate.
Study Overview
Detailed Description
Heart Failure (HF) is a growing and challenging public health concern in the United States. Current data suggest that there are about 5 million heart failure patients in this country with an additional 550,000 patients being diagnosed with this syndrome each year for the first time. Despite the significant advances in the management strategy of heart failure patients in the last 1-2 decades, there are about 1 million hospital admissions each year for Acute Decompensated Heart Failure (ADHF), almost double the number seen 15 years ago. The readmission rate for these patients at 6-month following discharge approaches about 50% with estimated 5-year mortality of 50%. Approximately, $23 billion are spent for the inpatient management of HF patients with another $40 billion for outpatient care. This prevailing situation mandates further exploration of novel therapeutic targets to treat this complex disease.
Chronic HF is accompanied by a sustained elevation in sympathetic nervous system activity, which is thought to be an important component in the pathophysiology and progression of the disease. HF patients also show abnormal breathing pattern with an increased respiratory rate and a lower tidal volume. Faster respiratory rate is associated with higher levels of sympathetic activity and potentiation of the chemoreflex response to hypoxia and hypercapnia. The relationship between sympathetic activity and spontaneous breathing rate is independent of age, body mass index, physical activity levels, percentage of body fat, or blood pressure. The arterial baroreflex sensitivity is also reduced in patients with heart failure. All these factors contribute to the distressing symptoms of fatigue, dyspnea and exercise intolerance in these patients.
Yoga trainees learn to breathe slowly, at a rate of about six breaths per minute, mobilizing in sequence the diaphragm and the upper and the lower chest. A handful of studies in normal subjects undergoing intensive training in yogic breathing techniques have demonstrated a marked improvement in cardiac hemodynamic parameters (cardiac output, cardiac index, stroke volume etc.), but such studies have not been conducted in patients with heart failure.
The purpose of our study is to evaluate the changes in cardiac hemodynamic parameters (cardiac output, cardiac index and thoracic fluid content) in patients with acute heart failure, chronic ambulatory heart failure and normal healthy subjects after a trial of controlled slow breathing. Subjects would undergo non-invasive measurement of cardiac hemodynamics while spontaneously breathing. They would then be given instructions in slow breathing at a rate of 6 to 10 breaths per minute and asked to practice it for some time using heart rate variability as biofeedback mechanism. Hemodynamic measurements would be repeated during and after the trial of slow breathing. The difference between these measurements would then be statistically analyzed. We hypothesize that even a short trial of controlled slow breathing using a biofeedback mechanism in patients with HF would produce significant favorable improvement in cardiac hemodynamics.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19141
- Albert Einstein Healthcare Network
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: NORMAL SUBJECTS
- Normal subject without history, signs-symptoms or diagnosis of heart failure
- Age over 18 and willing and able to provide informed consent.
Exclusion Criteria: NORMAL SUBJECTS
- Known allergy to electrode gel and medical adhesive used on electrocardiographic electrodes.
- Pregnancy (as any effect of this device use on pregnancy is not known).
- Patient belonging to a vulnerable population such as institutionalized persons, prisoners and persons with decisional incapacity or dementia.
- Presence of severe aortic regurgitation.
- Second degree Mobitz type II or third degree heart block, unless treated with a cardiac pacemaker.
- Implantation of a left ventricular assists device, hemodynamic monitor, activated minute ventilation pacemaker, or biventricular pacemaker (Cardiac Resynchronization Therapy) with the V-to-V interval set at more than 5 milliseconds offset.
- Implantation of a cardiac resynchronization device within the last 30 days.
Inclusion Criteria: CHRONIC AMBULATORY HEART FAILURE
- Patients over the age of 18 and able to give consent
- Ability to understand and willing to sign informed consent
- Diagnosis of Chronic Heart Failure and currently on optimal medical therapy
Exclusion Criteria: CHRONIC AMBULATORY HEART FAILURE
- NYHA class III/ IV heart failure symptoms despite treatment with diuretics.
- Co-existent pulmonary disease such as asthma/ COPD/ interstitial lung disease.
- Known allergy to electrode gel and medical adhesive used on electrocardiographic electrodes.
- Pregnancy (as any effect of this device use on pregnancy is not known).
- Patient belonging to a vulnerable population such as institutionalized persons, prisoners and persons with decisional incapacity or dementia.
- Presence of severe aortic regurgitation.
- Second degree Mobitz type II or third degree heart block, unless treated with a cardiac pacemaker.
- Implantation of a left ventricular assists device, hemodynamic monitor, activated minute ventilation pacemaker, or biventricular pacemaker (Cardiac Resynchronization Therapy) with the V-to-V interval set at more than 5 milliseconds offset.
- Implantation of a cardiac resynchronization device within the last 30 days.
Inclusion Criteria: ACUTE HEART FAILURE
- Patients over the age of 18 willing to and able to provide informed consent.
- Patients admitted to the hospital with acute congestive heart failure (evidenced by pulmonary edema by CXR, BNP> 500 pg/ml, jugular venous distension (JVD), crackles/ rales, dependent edema) who have been stabilized with medical therapy with evidence of euvolemia by at least two of the following: clearance of rales/ crackles, decrease in JVD, reduction in peripheral edema, decrease in BNP by at least 20%, no evidence of pulmonary edema on CXR.
Exclusion Criteria: ACUTE HEART FAILURE
- NYHA class III/ IV despite treatment with diuretics.
- Co-existent pulmonary disease such as asthma/ COPD/ interstitial lung disease.
- Known allergy to electrode gel and medical adhesive used on electrocardiographic electrodes.
- Pregnancy (as any effect of this device use on pregnancy is not known)..
- Patient belonging to a vulnerable population such as institutionalized persons, prisoners and persons with decisional incapacity or dementia.
- Presence of severe aortic regurgitation.
- Second degree Mobitz type II or third degree heart block, unless treated with a cardiac pacemaker.
- Implantation of a left ventricular assist device, hemodynamic monitor, activated minute ventilation pacemaker, or biventricular pacemaker (Cardiac Resynchronization Therapy) with the V-to-V interval set at more than 5 milliseconds offset.
- Implantation of a cardiac resynchronization device within the last 30 days.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Normal Healthy Subjects
Normal healthy subjects without history, signs-symptoms or diagnosis of heart failure
|
The subjects will be given instructions in slow breathing at a rate of 6 to 10 breaths per minute and asked to practice it for some time.
Hemodynamic measurements would be repeated before, during and after the trial of slow breathing.
A Noninvasive Cardiac Output Monitor will be used.
It uses a technology called impedance to measure cardiac output and other hemodynamic parameters by the passage of electric currents through the thorax.
This device uses four electrode stickers applied to the thorax and the neck.
|
Other: Chronic Ambulatory Heart Failure
Diagnosis of Chronic Heart Failure and currently on optimal medical therapy
|
The subjects will be given instructions in slow breathing at a rate of 6 to 10 breaths per minute and asked to practice it for some time.
Hemodynamic measurements would be repeated before, during and after the trial of slow breathing.
A Noninvasive Cardiac Output Monitor will be used.
It uses a technology called impedance to measure cardiac output and other hemodynamic parameters by the passage of electric currents through the thorax.
This device uses four electrode stickers applied to the thorax and the neck.
|
Other: Acute Heart Failure
Patients admitted to the hospital with acute congestive heart failure.
|
The subjects will be given instructions in slow breathing at a rate of 6 to 10 breaths per minute and asked to practice it for some time.
Hemodynamic measurements would be repeated before, during and after the trial of slow breathing.
A Noninvasive Cardiac Output Monitor will be used.
It uses a technology called impedance to measure cardiac output and other hemodynamic parameters by the passage of electric currents through the thorax.
This device uses four electrode stickers applied to the thorax and the neck.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluate the changes in cardiac hemodynamic parameters (Cardiac output, cardiac index, and thoracic fluid content) between normal, acute HF and chronic HF subjects with a trial of controlled slow breathing with biofeedback.
Time Frame: Half hour
|
Half hour
|
Collaborators and Investigators
Investigators
- Principal Investigator: Darshak H Karia, MD, Albert Einstein Healthcare Network
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HN 4025
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
US Department of Veterans AffairsCompleted
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
Clinical Trials on Slow breathing
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH); Oregon Clinical...CompletedPost-Traumatic Stress DisordersUnited States
-
Queen Mary University of LondonCompletedGastro Esophageal RefluxUnited Kingdom
-
Queen Mary University of LondonCompleted
-
Vanderbilt University Medical CenterNational Center for Complementary and Integrative Health (NCCIH)CompletedStress | Healthy AdultsUnited States
-
Texas State UniversityCompleted
-
Spaulding Rehabilitation HospitalEnrolling by invitationSpinal Cord Injuries | Slow BreathingUnited States
-
Vanderbilt University Medical CenterWithdrawnCongestive Heart Failure
-
Texas State UniversityRecruiting
-
Penang Hospital, MalaysiaMinistry of Health, MalaysiaUnknown
-
Health and Human Performance FoundationCompleted